Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.11
-0.02-2.19%
At close: -
$1.07
-0.04-4.04%
After Hours: Feb 25, 6:53 PM EDT
Comments
Loading...
AN2 Therapeutics (ANTX) Forecast
NewsEarningsAN2 Therapeutics (ANTX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
AN2 Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ANTX | Benzinga
Explore AN2 Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ANTX.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy AN2 Therapeutics (ANTX) stock?
You can purchase shares of AN2 Therapeutics (NASDAQ:ANTX) through any online brokerage.
Who are AN2 Therapeutics (ANTX) competitors?
Other companies in AN2 Therapeutics’s space includes: Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC) and Rani Therapeutics Hldgs (NASDAQ:RANI).
What is the forecast, or price target, for AN2 Therapeutics (ANTX) stock?
AN2 Therapeutics has a consensus price target of $11.80.
What is the current price for AN2 Therapeutics (ANTX)?
The stock price for AN2 Therapeutics (NASDAQ: ANTX) is $1.07 last updated February 25, 2025 at 6:53 PM EST.
Does AN2 Therapeutics (ANTX) pay a dividend?
A quarterly cash dividend of 0.66 per share of Class A Common Stock. The quarterly cash dividend was payable on February 1, 2018 to stockholders of record on January 11, 2018.
When is AN2 Therapeutics (NASDAQ:ANTX) reporting earnings?
AN2 Therapeutics’s Q1 earnings are confirmed for Tuesday, May 13, 2025.
Is AN2 Therapeutics (ANTX) going to split?
There is no upcoming split for AN2 Therapeutics.
What sector and industry does AN2 Therapeutics (ANTX) operate in?
AN2 Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.